Tactics for Communicating Investigator Sponsored Trials for Congresses/ ISTs and MSLs’ Involvement

STUDY OVERVIEW

KEY TOPICS

• Types of IST Studies Supported by Organizations
• Type of Information and Tools Used for Sharing IST Information
• Reasons for Not Promoting ISTs Proactively for Congresses
• Caveats to Legal/Regulatory/Compliance Approval
• Involvement of MSLs, Permission to MSLs and Lessons Learned

KEY METRICS

• Which of the listed tools have you used to raise awareness or advertise ISTs from your company at your Medical Affairs booth?
• What type of information do you provide in relation to ISTs?
• Are MSLs within your organization allowed to include in a post-conference slide deck, scientific information presented at the congress on products not owned/marketed by your company?
• If asked unsolicited about IST data, under scientific exchange are your MSLs allowed to answer questions on products not owned/marketed by your company?

SAMPLE KEY FINDINGS

• All companies have used MSLs to promote ISTs, at some point: Surveyed companies all said they have used MSLs at scientific congresses or while in the field to promote ISTs that will be featured at a given congress. No other tactic has been used by more than 29% (meeting brochures/program books and panels at the medical affairs booth providing an IST overview).

METHODOLOGY

Best Practices, LLC engaged 10 medical affairs leaders from 9 bio-pharmaceutical companies through a benchmarking survey instrument.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.